HighTower Advisors
BEAT

HighTower Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

HighTower Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,553
Closed -$807K – 2468
2018
Q3 		$807K Buy
12,553
+51
+0.4% +$2.85K 0.01% 1226
2018
Q2 		$558K Buy
+12,502
New +$499K ﹤0.01% 1395

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HighTower Advisors's BEAT Position: Q4 2018 in Review

HighTower Advisors sold out of BioTelemetry, Inc. (BEAT) in Q4 2018, closing a stake of 12,553 shares — an estimated $807K sold.

HighTower Advisors first reported a position in BEAT in Q2 2018 and held it in 2 quarters. The position peaked at $807K in Q3 2018. 281 funds tracked by Wall St. Rank hold BEAT as of Q4 2018.

  • HighTower Advisors reported no remaining BioTelemetry, Inc. position as of Q4 2018 after selling out during the quarter.
  • HighTower Advisors sold 12,553 BioTelemetry, Inc. shares in Q4 2018, an estimated $807K.
  • HighTower Advisors first reported a position in BioTelemetry, Inc. in Q2 2018 and held it in 2 quarters.
  • HighTower Advisors's BioTelemetry, Inc. position peaked at $807K in Q3 2018.
  • 281 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2018.

Based on HighTower Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.